Filing Details

Accession Number:
0001179110-19-003120
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-04 17:30:40
Reporting Period:
2019-02-28
Accepted Time:
2019-03-04 17:30:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1695686 J Joseph Manning 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2019-02-28 7,288 $0.00 61,324 No 4 A Direct
Common Shares Without Par Value Disposition 2019-02-28 3,959 $77.23 57,365 No 4 F Direct
Common Shares Without Par Value Disposition 2019-03-01 1,223 $78.00 56,142 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.